CN101342302A - Traditional Chinese medicine composing prescription for treating children's upper respiratory tract infection fever - Google Patents
Traditional Chinese medicine composing prescription for treating children's upper respiratory tract infection fever Download PDFInfo
- Publication number
- CN101342302A CN101342302A CNA2008101395652A CN200810139565A CN101342302A CN 101342302 A CN101342302 A CN 101342302A CN A2008101395652 A CNA2008101395652 A CN A2008101395652A CN 200810139565 A CN200810139565 A CN 200810139565A CN 101342302 A CN101342302 A CN 101342302A
- Authority
- CN
- China
- Prior art keywords
- respiratory tract
- upper respiratory
- tract infection
- parts
- fever
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a Chinese medicinal formula which is used for treating upper respiratory tract infection of infants. The formula is characterized by comprising the ingredients of the following weight portions: 8 to 12 portions of plaster stone, 2 to 4 portions of rhizoma anemarrhenae, 2 to 4 portions of Yuanshen, 2 to 4 portions of Chinese yam and 0.5 to 1.5 portion(s) of licorice. And the invention has obvious effects on the upper respiratory tract infection of infants, long-time fever, red coated tongue, bleeding of nose, and tetter.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation for the treatment of infant upper respiratory tract infection, belong to pure herbal composite.
Background technology
Upper respiratory tract infection is one of modal disease of children's, especially is more common in winter-spring season.The main diseases that causes upper respiratory tract infection is because of being virus, and minority is to be caused by antibacterial or mycoplasma pneumoniae.Light disease mainly is stream clear water nasal mucus, sneeze, cough slightly, pharyngalgia, tired, indigestion and loss of appetite, and low grade fever can be arranged, and the about 3-4 of the course of disease days, minority continued more than 1 week; The serious symptom infant can accompany hyperpyrexia, hacking cough, agitation, minority that hyperpyrexia convulsion can be arranged.Prognosis is generally good, but the weakling can cause complication such as otitis media, cervical lymphadenitis, retropharyngeal abscess, and the only a few case can be led to viral myocarditis.Spread downwards as inflammation and can cause bronchitis or pneumonia.Usually on the basis of viral infection, merge bacterial infection.Existing Therapeutic Method generally adopts antibiotherapy, and unrestrictedly drop simply so not only damages human body, strengthen the treatment cost, when following infection fever, double to use antibiotic, vicious cycle again, cause the immunity disappearance, therapeutic effect also often can not be satisfactory.
Summary of the invention
The technical problem that the present invention solves is, a kind of Chinese prescription for the treatment of children's upper respiratory tract infection fever is provided, and by selecting suitable Chinese medicine and consumption proportion thereof, reaches the purpose that antiinflammatory is cured.
The technical solution adopted in the present invention is as follows:
The Chinese prescription of treatment children's upper respiratory tract infection fever, it is characterized in that: it is composed of the following components: Gypsum Fibrosum 8-12 part, Rhizoma Anemarrhenae 2-4 part, Radix Scrophulariae 2-4 part, Rhizoma Dioscoreae 2-4 part, Radix Glycyrrhizae 0.5-1.5 part mixes.
Described part is meant mass parts.
Preferred ingredients content is: 10 parts of Gypsum Fibrosum, 3 parts of the Rhizoma Anemarrhenaes, 3 parts of Radix Scrophulariae, 3 parts of Rhizoma Dioscoreaes, 1 part in Radix Glycyrrhizae.
Chinese herbal medicine of the present invention is according to traditional medicine and modern medicine analysis, and the property of medicine and pharmacological action are as follows:
Gypsum Fibrosum: meridian distribution of property and flavor: Great Cold; Hot, sweet; Attach to the lung and stomach meridians.Function cures mainly: clearing away heat-fire, relieving restlessness is quenched the thirst.Be used for fever caused by exogenous pathogenic factors, hyperpyrexia excessive thirst, dyspnea and cough due to lung-heat, the high Sheng of stomach-fire, headache, toothache.
The Rhizoma Anemarrhenae: meridian distribution of property and flavor: cold; Bitter, sweet; Return lung, stomach, kidney channel.Function cures mainly: clearing away heat-fire, promote the production of body fluid and moisturize.Be used for fever caused by exogenous pathogenic factors, the hyperpyrexia excessive thirst, lung-heat type cough, osteopyrexia and fever, interior-heat is quenched one's thirst, the dryness of the intestine constipation.
Radix Scrophulariae: meridian distribution of property and flavor: be slightly cold; Sweet, bitter, salty; Return lung, stomach, kidney channel.Function cures mainly: removing heat from blood YIN nourishing, eliminating fire and detoxication.Be used for consumption of YIN caused by febrile disease, conjunctival congestion, pharyngalgia, scrofula, diphtheria, carbuncle sore tumefacting virus.
Rhizoma Dioscoreae: meridian distribution of property and flavor: flat; Sweet; Return spleen, lung, kidney channel.Function cures mainly: supplementing QI and nourishing YIN, spleen reinforcing lung kidney, treating spontaneous emission and leukorrhagia.Be used for insufficiency of the spleen lack of appetite, incessant chronic diarrhea, the deficiency of the lung is breathed with cough, emission due to deficiency of the kidney, leukorrhagia, frequent micturition, deficiency-heat is quenched one's thirst.
Radix Glycyrrhizae: meridian distribution of property and flavor: flat; Sweet; GUIXIN, lung, spleen, stomach warp.Function cures mainly: invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.Be used for weakness of the spleen and stomach, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, gastral cavity abdomen, the anxious pain of extremity contraction, carbuncle sore tumefacting virus, cushion toxicity, strong.
The present invention sheerly prepared from traditional Chinese medicines forms, and is a kind of Chinese medicine for oral administration, and for treatment children's upper respiratory tract concurrent infection, the fever time is long, and tongue fur is red, and nose is bled, and has the effect of erythra person's effect all more obvious.
The specific embodiment
In order to understand better and to implement, further specify the present invention below in conjunction with embodiment.
Embodiment one: get 8 parts of Gypsum Fibrosum, 2 parts of the Rhizoma Anemarrhenaes, 2 parts of Radix Scrophulariae, 2 parts of Rhizoma Dioscoreaes, Radix Glycyrrhizae is decocted in water for oral dose for 0.5 part, every day potion, three sub-services.
Embodiment two: get 10 parts of Gypsum Fibrosum, 3 parts of the Rhizoma Anemarrhenaes, 3 parts of Radix Scrophulariae, 3 parts of Rhizoma Dioscoreaes, Radix Glycyrrhizae is decocted in water for oral dose for 1 part, every day potion, three sub-services.
Embodiment three: get 12 parts of Gypsum Fibrosum, 4 parts of the Rhizoma Anemarrhenaes, 4 parts of Radix Scrophulariae, 4 parts of Rhizoma Dioscoreaes, Radix Glycyrrhizae is decocted in water for oral dose for 1.5 parts, every day potion, three sub-services.
Below be clinical use curative effect situation:
With medicine treatment children's upper respiratory tract infection fever epistaxis 18 examples of the present invention, the result shows medicine group obvious effective rate 83% of the present invention, total effective rate 100%.
Claims (2)
1, a kind of Chinese prescription for the treatment of children's upper respiratory tract infection fever, it is characterized in that: it is composed of the following components: Gypsum Fibrosum 8-12 part, Rhizoma Anemarrhenae 2-4 part, Radix Scrophulariae 2-4 part, Rhizoma Dioscoreae 2-4 part, Radix Glycyrrhizae 0.5-1.5 part mixes.Described part is meant mass parts.
2, the Chinese prescription of treatment children's upper respiratory tract infection fever as claimed in claim 1, it is characterized in that: it is composed of the following components: 10 parts of Gypsum Fibrosum, 3 parts of the Rhizoma Anemarrhenaes, 3 parts of Radix Scrophulariae, 3 parts of Rhizoma Dioscoreaes, Radix Glycyrrhizae is mixed into for 1 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008101395652A CN101342302A (en) | 2008-08-19 | 2008-08-19 | Traditional Chinese medicine composing prescription for treating children's upper respiratory tract infection fever |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008101395652A CN101342302A (en) | 2008-08-19 | 2008-08-19 | Traditional Chinese medicine composing prescription for treating children's upper respiratory tract infection fever |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101342302A true CN101342302A (en) | 2009-01-14 |
Family
ID=40244494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2008101395652A Pending CN101342302A (en) | 2008-08-19 | 2008-08-19 | Traditional Chinese medicine composing prescription for treating children's upper respiratory tract infection fever |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101342302A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102641421A (en) * | 2012-05-15 | 2012-08-22 | 湖北梦阳药业股份有限公司 | Figwort Shangqing gula tablet |
| CN103479853A (en) * | 2013-08-28 | 2014-01-01 | 严中明 | Chinese medicinal composition for excessive lung channel heat type epistaxis patients |
| CN107149655A (en) * | 2016-03-04 | 2017-09-12 | 杨朋会 | Resist white blood glue capsule |
-
2008
- 2008-08-19 CN CNA2008101395652A patent/CN101342302A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102641421A (en) * | 2012-05-15 | 2012-08-22 | 湖北梦阳药业股份有限公司 | Figwort Shangqing gula tablet |
| CN102641421B (en) * | 2012-05-15 | 2013-09-04 | 湖北梦阳药业股份有限公司 | Figwort Shangqing gula tablet |
| CN103479853A (en) * | 2013-08-28 | 2014-01-01 | 严中明 | Chinese medicinal composition for excessive lung channel heat type epistaxis patients |
| CN107149655A (en) * | 2016-03-04 | 2017-09-12 | 杨朋会 | Resist white blood glue capsule |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102743737B (en) | Chinese medicinal preparation for effectively treating tracheitis | |
| CN103961533A (en) | Traditional Chinese medicine atomizing agent for treating pharyngitis | |
| CN101342328A (en) | Traditional Chinese medicine composing prescription for treating children's bacterial upper respiratory tract infection | |
| CN103610911A (en) | Medicine for treating bronchitis | |
| CN101647979B (en) | Traditional Chinese medicine for treating bronchial asthma | |
| CN103169885A (en) | Traditional Chinese medicine composition for treating infantile asthma | |
| CN102526681A (en) | Traditional Chinese medicinal composition for treating allergic rhinitis | |
| CN103285271B (en) | Traditional Chinese medicine for treating internal heat type pleurisy due to yin deficiency | |
| CN101342302A (en) | Traditional Chinese medicine composing prescription for treating children's upper respiratory tract infection fever | |
| CN102512540B (en) | Chinese medicine composition for treating asthma | |
| CN104208473A (en) | Traditional Chinese medicine composition for treating wind-heat type cough and asthma and use thereof | |
| CN103705890A (en) | Pharmaceutical composition with function of removing heat from lung to relieve cough | |
| CN102188619A (en) | Traditional Chinese medicine for treating radiation pneumonia | |
| CN101342327B (en) | Traditional Chinese medicine composing prescription for treating children's upper respiratory tract infection | |
| CN101199743A (en) | Chinese medicine compound for oral administration for treating chronicity sinusitis | |
| CN103638360A (en) | Chinese medicine powder for treating nasosinusitis | |
| CN101112509B (en) | Oral administration Chinese traditional medicine composition for treating chronic sinusitis | |
| CN103495130B (en) | Traditional Chinese medicine composition for treating asthma | |
| CN105816608A (en) | Chinese herbal medicine formula for treating bronchial asthma | |
| CN101357200A (en) | Medicine for treating chronic faucitis | |
| CN101062301A (en) | Traditional Chinese medicine formula for treating chronic bronchitis caused by cold | |
| CN104606533A (en) | Traditional Chinese medicine decoction for treating pharyngitis | |
| CN109820998A (en) | A kind of application for improveing Xiao Qinglong Tang and its treating respiratory disease | |
| CN103494983A (en) | Traditional Chinese medicine for treating influenza | |
| CN103223075B (en) | Traditional Chinese medicinal capsule for treating diphtheria |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090114 |